|
|||||
|
|
Cost-effectiveness of exenatide versus insulin glargine in Spanish patients with obesity and type 2 diabetes mellitus |
|
| Affiliation: | a IMS Health, Basilea, Suiza b Unidad de Investigación de Resultados Sanitarios, Eli Lilly, Alcobendas, Madrid, España c European Outcomes Research, Eli Lilly, Windlesham, Surrey, Reino Unido d Departamento Médico, Eli Lilly, Alcobendas, Madrid, España |
| Abstract: | |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ | |